-
Study aim
-
Determining the Effect of Vitamin A on persistent wheezing of Infants with bronchiolitis admitted to Ali ibn Abi Talib hospital of Zahedan
-
Design
-
A randomized, without blindness, sham-controlled clinical trial with a parallel group postoperative care and outcome assessment, design of 60 patients, enrolled between March 2018 and March 2019 and followed for one year
-
Settings and conduct
-
This study will be performed in Imam Ali Hospital in Zahedan. 60 infants aged 1 month to 2 years are included in the study after confirming of bronchiolitis by a specialist and no history of previous disease. Patients will be divided into two groups of case and control with random blocks. Then, the patient's demographic information and severity of symptoms will be recorded. For both groups, the usual treatment of bronchiolitis and for the case group also 5,000 units per kg of body weight of the injected vitamin A will be prescribed. Then, all patients will be visited regarding severity of symptoms by one assisted pediatrician, 24 hours after injection (during hospitalization), at the time of discharge, and 2 weeks after that.
-
Participants/Inclusion and exclusion criteria
-
After getting history and performing a physical examination, Infants with bronchiolitis from one month to two years were included to the study and patients with a history of congenital heart disease, pulmonary, asthma or other immunodeficiencies and other chronic diseases, also if the diagnose changed during this study, were excluded.
-
Intervention groups
-
The intervention group consists of 30 infants who receive the usual treatment of Bronchiolitis, such as Cold Oxygen Steam and Bronchodilator and 5,000 units per kg body weight of injected vitamin A.
-
Main outcome variables
-
severity of wheezing, retraction status, respiratory rate, and general condition of the patient